Skip to main content
. 2018 Nov 12;8:16671. doi: 10.1038/s41598-018-35119-7

Figure 5.

Figure 5

Validation of proteomics results regarding PAI-1 on endothelial cells treated with atorvastatin (Atorva) or by DKK-1 silencing as described in the Material and methods section (n = 3). Effect on PAI-1 mRNA levels exerted by siDKK-1 (a) or atorvastatin (b). PAI-1 was evaluated at antigen levels by ELISA in cells treated with siDKK-1 (c), atorvastatin (d) or recombinant DKK-1 (e). The data are expressed as ng/ml of PAI-1. Values are the mean ± SEM of 3 individual experiments.*p < 0.05 vs siNEG or control cells.